Issue link: http://osercommunicationsgroup.uberflip.com/i/562622
C h a i n D r u g s t o r e D a i l y 1 7 S u n d a y, A u g u s t 2 3 , 2 0 1 5 RXNET PROVIDES REVOLUTIONARY AUTOMATED RX PRICING FOR CHAIN PHARMACIES By Chuck Cannata, President, RxNet, Inc. Pharmacies struggling with staff discre- tionary pricing, frequent overrides, paid at U&C events, flat or shirking margins, cost increases and staying competitive in their market areas will benefit from RxNet's automated suite of pharmacy pricing. Pharmacies that purchase additional pharmacies or migrate from one pharma- cy system to another will also benefit from our services in that we can seam- lessly translate incumbent pricing to a new location or new pharmacy system without any degradation in pricing accu- racy. We deliver an automated solution that is easy to use, more than pays for itself every month, requires no staff train- ing and doesn't generate additional switch fees. We offer complete control over your pricing and allow you to manage pricing on every drug you dispense for any number of locations with a single, easy to use interface. Pharmacies can expect to benefit from the implementation of our servic- es in the following ways: 1) reduced paid at U&C events and time spent reversing and resubmitting Rx's; 2) reduced repeat paid at U&C events on the same drug; 3) improved price con- sistency; 4) increased profit and mar- gin; 5) reduced overrides; 6) improved patient experience; and 7) increased more profitable cash business. We use your actual pharmacy third party expe- riences, your staff override patterns, your pre-rebate costs and market pricing from your area to deliver a comprehensive, highly effective pricing solution that is cost effective and easy to use. If you're interested in improving margins, third party payments, price consistency or increasing patient count, please feel free to contact us for a no obligation evaluation. Visit RxNet at booth #3416. For more infor- mation, go to www.rxnetusa.com, call 866.506.3044 or email info@rxnetusa.com. NEW DERMATOLOGICAL PRODUCTS FROM TAGI PHARMA TAGI Pharma is pleased to announce the expansion of its dermatological line. Nivatopic Plus Cream is a skin barri- er repair therapy commonly used for eczema and various types of skin condi- tions. It is available in a 100 gram tube and 450 gram jar (pump dispensing mechanism). Launched second quarter 2014, Nivatopic Plus is the newest addi- tion to TAGI Pharma's dermatological treatments. Consumer coupons available. GCN #30324. Benzoyl Peroxide Emollient Foam (aerosol foam) acne medication is now available in 5.3 percent 60 gram, 5.3 per- cent 100 gram and 9.8 percent 100 gram. Launched fourth quarter 2013, Benzoyl Peroxide Emollient Foam is ready avail- able at your preferred wholesaler. Consumer coupons available. GCN# 27596 and 29303. Astringent Solution Powder Pack is a generic alternative to Bayer's Domeboro ® . This over the counter prod- uct provides soothing, effective relief of minor skin irritations due to poison ivy, athlete's foot, insect bites and rashes. Consumer coupons are available. GCN #31828. About TAGI Pharma, Inc. Established in 2010, TAGI Pharma is a wholly owned subsidiary of Precision Dose, Inc. Headquartered in South Beloit, Illinois, TAGI Pharma was founded with the purpose of penetrating the retail seg- ment and expanding generic opportuni- ties. With a robust pipeline and product mix, TAGI Pharma is providing market opportunities in both retail and institu- tional segments. It maintains product emphasis on tablets and capsules while encompassing liquids, powders, creams and ointments. TAGI's strength is derived from an understanding of the market and identification of product o p p o r t u n i t i e s . Its marketing mix utilizes var- ious platforms c o m p o u n d e d into the TAGI formulation. Its product quality and high service levels drive performance. All TAGI Pharma products are available through your preferred wholesale distrib- utor throughout the United States. Made in America. Visit TAGI Pharma at booth #1204. Go online to www.tagipharma.com to view complete product listings and full pre- scribing information which includes indi- cations for use and additional important safety information. TRICALM RELEASES NEW PRODUCTS Cosmederm Bioscience, Inc. recently announced the expansion of its itch-relief product line, TriCalm ® , with the new TriCalm Clinical Repair Cream and TriCalm Extra Strength Spray. Following the success of the company's initial prod- uct, TriCalm Hydrogel, these two new offerings strategically expand the brand's line of steroid-free, anti-itch products to further benefit sufferers of itch. Clinical Repair Cream is ideal for those suffering from dry, itchy skin, while Extra Strength Spray is formulated for use on contagious or hard-to-reach areas, such as rashes from poison oak or ivy. The new products are available in select retail stores and online at Amazon.com. Like Hydrogel, the new TriCalm Clinical Repair Cream and TriCalm Extra Strength Spray have been awarded the National Eczema Association Seal of Acceptance™, recognizing them as prod- ucts appropriate for the care of itch relat- ed to sensitive skin or eczema, a condi- tion that affects roughly thirty million Americans. "Because no itch is exactly the same, itch sufferers can't be easily categorized," said Sean Edwards, Chief Executive Officer and President, Cosmederm Bioscience, Inc. "Through our research, we recognized a need to provide a broad- er selection of products for those who suf- fer from itch, ranging from an acute bug bite to chronic skin conditions. Our Clinical Repair Cream and Extra Strength Spray offer two new steroid-free solu- tions that provide effective relief, further advancing our company's mission to solve itch with innovative science." TriCalm Clinical Repair Cream Designed with chronic dry skin sufferers in mind, TriCalm Clinical Repair Cream is for- mulated with ceramides, shea butter, hyaluronic acid and patented ingredients to mois- turize and repair dry, itchy skin. It is ideal for those in need of daily hydration, itch relief and barrier repair due to conditions like eczema or atopic dermatitis. As with all TriCalm products, TriCalm Clinical Repair Cream is free of topical steroids, which are found in many common over-the-counter anti-itch prod- ucts, and provides itch relief without the unwanted side effects associated with steroid-based creams, such as skin thin- ning and discoloration. TriCalm Extra Strength Spray According to a study conducted by TriCalm, up to 58 percent of itch occurrences happen during the spring and summer months due to insect bites, skin irrita- tions and rash outbreaks. With its convenient, touch-less, spray-on formula, TriCalm Extra Strength Spray provides fast-acting itch relief for spring and summer skin irritations such as ath- lete's foot, bug bites, skin allergies and outdoor plant exposure, like poison ivy or oak. The spray, like all TriCalm products, is steroid free, safe for children as young as two, and can be applied as needed. For more information about TriCalm, contact Justin Brown at jbrown@cosmed- erm.com, call 858.550.7070 ext. 137 or visit www.tricalm.com. For sales informa- tion, contact David Biernbaum of David Biernbaum & Associates at david@ biernbaum.com, or call 314.434.6008. WIDE ARRAY OF INNOVATIVE PRODUCTS FROM CITRON PHARMA Citron Pharma's journey thus far has been very exciting. In less than two years, it has grown its portfolio quickly, currently marketing 25 molecules repre- senting 135 SKUs. With a substantial product offering now in hand, along with continued investments and an aspiration to grow the business, Citron is committed to providing its customers superior value and the high quality products they need. Citron's focus is to provide a wide array of innovative products that may be difficult to produce and have limited API's or challenging finished dose for- mulations. It is a strategy that is achieved through a combination of internal development and strategic part- nerships. Citron Pharma's business develop- ment efforts provide another source of synergies, allowing it to stay at the fore- front of launching unique and innovative products. It is actively licensing approved pharmaceutical ANDA prod- ucts to be marketed and distributed in the U.S. and seeks organic growth that will be supported by acquisitions and partner- ships. Citron Pharma also has successful strategic partnerships with multi- national organizations that wish to divest both branded and generic products. Citron looks for similar and innovative collaborations and paves the path for win-win business relation- ships in distinct therapies and key mar- kets. The expertise behind Citron presents it as a recognized marketing partner. It combines a passion for excellence with skillful proficiency to raise the perform- ance standards and exceed expectations by bringing value and quality to its cus- tomers. Some key strengths that the compa- ny prides itself in are dedicat- ed leadership, great service offerings and a sizeable prod- uct basket. Citron Pharma's strategic network with global pharmaceutical leaders offers enrichment of its product portfolio. Its research and development expertise in developing innovative products that meet customer needs and its unparal- leled access to fully integrated manu- facturing networks also add value. Citron Pharma aims to be the most respected and valued business partner to all of its customers. Visit Citron Pharma at booth #2406. For more information, go to www.citron pharma.com or call 732.227.1515.